Juvenile myelomonocytic leukemia

Active Research Protocols

  1. 01-C-0125 – Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies
  2. 04-C-0102 – Hematologic Malignancy Biology Study
  3. 06-C-0233 – A Phase I/II Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias
  4. 08-C-0079 – Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults with Neurofibromatosis Type 1
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014